FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3137106082> ?p ?o ?g. }

• W3137106082 endingPage "2109" @default.
• W3137106082 startingPage "2099" @default.
• W3137106082 abstract "Data regarding outcome of COVID-19 in patients with autoimmune hepatitis (AIH) are lacking.We performed a retrospective study on patients with AIH and COVID-19 from 34 centers in Europe and the Americas. We analyzed factors associated with severe COVID-19 outcomes, defined as the need for mechanical ventilation, intensive care admission, and/or death. The outcomes of patients with AIH were compared to a propensity score-matched cohort of patients without AIH but with chronic liver diseases (CLD) and COVID-19. The frequency and clinical significance of new-onset liver injury (alanine aminotransferase > 2 × the upper limit of normal) during COVID-19 was also evaluated. We included 110 patients with AIH (80% female) with a median age of 49 (range, 18-85) years at COVID-19 diagnosis. New-onset liver injury was observed in 37.1% (33/89) of the patients. Use of antivirals was associated with liver injury (P = 0.041; OR, 3.36; 95% CI, 1.05-10.78), while continued immunosuppression during COVID-19 was associated with a lower rate of liver injury (P = 0.009; OR, 0.26; 95% CI, 0.09-0.71). The rates of severe COVID-19 (15.5% versus 20.2%, P = 0.231) and all-cause mortality (10% versus 11.5%, P = 0.852) were not different between AIH and non-AIH CLD. Cirrhosis was an independent predictor of severe COVID-19 in patients with AIH (P < 0.001; OR, 17.46; 95% CI, 4.22-72.13). Continuation of immunosuppression or presence of liver injury during COVID-19 was not associated with severe COVID-19.This international, multicenter study reveals that patients with AIH were not at risk for worse outcomes with COVID-19 than other causes of CLD. Cirrhosis was the strongest predictor for severe COVID-19 in patients with AIH. Maintenance of immunosuppression during COVID-19 was not associated with increased risk for severe COVID-19 but did lower the risk for new-onset liver injury during COVID-19." @default.
• W3137106082 created "2021-03-29" @default.
• W3137106082 creator A5007351094 @default.
• W3137106082 creator A5009548457 @default.
• W3137106082 creator A5014348793 @default.
• W3137106082 creator A5020017677 @default.
• W3137106082 creator A5022864390 @default.
• W3137106082 creator A5022982610 @default.
• W3137106082 creator A5026784354 @default.
• W3137106082 creator A5028142090 @default.
• W3137106082 creator A5029366094 @default.
• W3137106082 creator A5030350842 @default.
• W3137106082 creator A5030413648 @default.
• W3137106082 creator A5035293166 @default.
• W3137106082 creator A5036104034 @default.
• W3137106082 creator A5038516591 @default.
• W3137106082 creator A5040726761 @default.
• W3137106082 creator A5042634035 @default.
• W3137106082 creator A5042824385 @default.
• W3137106082 creator A5045755229 @default.
• W3137106082 creator A5046804207 @default.
• W3137106082 creator A5047257447 @default.
• W3137106082 creator A5047772830 @default.
• W3137106082 creator A5048135465 @default.
• W3137106082 creator A5048480496 @default.
• W3137106082 creator A5048679092 @default.
• W3137106082 creator A5049189341 @default.
• W3137106082 creator A5049218834 @default.
• W3137106082 creator A5050556831 @default.
• W3137106082 creator A5053604265 @default.
• W3137106082 creator A5057435596 @default.
• W3137106082 creator A5058781782 @default.
• W3137106082 creator A5059807918 @default.
• W3137106082 creator A5060188988 @default.
• W3137106082 creator A5061567306 @default.
• W3137106082 creator A5062089029 @default.
• W3137106082 creator A5064622420 @default.
• W3137106082 creator A5065511179 @default.
• W3137106082 creator A5069415653 @default.
• W3137106082 creator A5072412994 @default.
• W3137106082 creator A5072574591 @default.
• W3137106082 creator A5072657987 @default.
• W3137106082 creator A5072837175 @default.
• W3137106082 creator A5073281041 @default.
• W3137106082 creator A5074017830 @default.
• W3137106082 creator A5074474756 @default.
• W3137106082 creator A5076343477 @default.
• W3137106082 creator A5078375697 @default.
• W3137106082 creator A5083255246 @default.
• W3137106082 creator A5084697737 @default.
• W3137106082 date "2021-06-01" @default.
• W3137106082 modified "2023-10-18" @default.
• W3137106082 title "Outcome of COVID‐19 in Patients With Autoimmune Hepatitis: An International Multicenter Study" @default.
• W3137106082 cites W2032703707 @default.
• W3137106082 cites W2331543379 @default.
• W3137106082 cites W2791839818 @default.
• W3137106082 cites W2995815973 @default.
• W3137106082 cites W3001118548 @default.
• W3137106082 cites W3008028633 @default.
• W3137106082 cites W3008554056 @default.
• W3137106082 cites W3008827533 @default.
• W3137106082 cites W3012925204 @default.
• W3137106082 cites W3024016727 @default.
• W3137106082 cites W3024177957 @default.
• W3137106082 cites W3032031508 @default.
• W3137106082 cites W3033189130 @default.
• W3137106082 cites W3033659145 @default.
• W3137106082 cites W3034082177 @default.
• W3137106082 cites W3034241701 @default.
• W3137106082 cites W3041135491 @default.
• W3137106082 cites W3046501796 @default.
• W3137106082 cites W3085849982 @default.
• W3137106082 cites W3087358376 @default.
• W3137106082 cites W3095052351 @default.
• W3137106082 cites W3097670735 @default.
• W3137106082 cites W3111117846 @default.
• W3137106082 doi "https://doi.org/10.1002/hep.31797" @default.
• W3137106082 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8250536" @default.
• W3137106082 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33713486" @default.
• W3137106082 hasPublicationYear "2021" @default.
• W3137106082 type Work @default.
• W3137106082 sameAs 3137106082 @default.
• W3137106082 citedByCount "54" @default.
• W3137106082 countsByYear W31371060822021 @default.
• W3137106082 countsByYear W31371060822022 @default.
• W3137106082 countsByYear W31371060822023 @default.
• W3137106082 crossrefType "journal-article" @default.
• W3137106082 hasAuthorship W3137106082A5007351094 @default.
• W3137106082 hasAuthorship W3137106082A5009548457 @default.
• W3137106082 hasAuthorship W3137106082A5014348793 @default.
• W3137106082 hasAuthorship W3137106082A5020017677 @default.
• W3137106082 hasAuthorship W3137106082A5022864390 @default.
• W3137106082 hasAuthorship W3137106082A5022982610 @default.
• W3137106082 hasAuthorship W3137106082A5026784354 @default.
• W3137106082 hasAuthorship W3137106082A5028142090 @default.
• W3137106082 hasAuthorship W3137106082A5029366094 @default.
• W3137106082 hasAuthorship W3137106082A5030350842 @default.
• W3137106082 hasAuthorship W3137106082A5030413648 @default.

• next